Overexpression of megsin induces mesangial cell proliferation and excretion of type IV collagen in vitro

2011 ◽  
Vol 271 (2) ◽  
pp. 413-417 ◽  
Author(s):  
Yunfeng Xia ◽  
Yimin Zhang ◽  
Wei Shi ◽  
Shuangxin Liu ◽  
Yuanhan Chen ◽  
...  
1999 ◽  
Vol 56 ◽  
pp. S97-S100 ◽  
Author(s):  
Motonobu Nishimura ◽  
Tomoaki Tanaka ◽  
Tatsuji Yasuda ◽  
Shinichi Kurakata ◽  
Masatoshi Kitagawa ◽  
...  

1997 ◽  
Vol 51 (6) ◽  
pp. 1838-1846 ◽  
Author(s):  
Masashi Haraguchi ◽  
Mikio Okamura ◽  
Masayo Konishi ◽  
Yoshio Konishi ◽  
Nobuo Negoro ◽  
...  

1999 ◽  
Vol 56 (6) ◽  
pp. 2085-2095 ◽  
Author(s):  
Seiji Inoshita ◽  
Yoshio Terada ◽  
Osamu Nakashima ◽  
Michio Kuwahara ◽  
Sei Sasaki ◽  
...  

1998 ◽  
Vol 101 (11) ◽  
pp. 2589-2597 ◽  
Author(s):  
Y Maeshima ◽  
N Kashihara ◽  
T Yasuda ◽  
H Sugiyama ◽  
T Sekikawa ◽  
...  

2012 ◽  
Vol 351 (2) ◽  
pp. 337-341 ◽  
Author(s):  
Dusica Vasic ◽  
Andreas Spyrantis ◽  
Renate Durst ◽  
Helga Bach ◽  
Sonja Vogt ◽  
...  

Nutrients ◽  
2019 ◽  
Vol 11 (2) ◽  
pp. 483 ◽  
Author(s):  
Zhonghua Dong ◽  
Yueyue Sun ◽  
Guangwei Wei ◽  
Siying Li ◽  
Zhongxi Zhao

(1) Background: Diabetic nephropathy, a microvascular complication of diabetes, is one of the principal causes of end-stage renal disease worldwide. The aim of this study was to explore the therapeutic effects of ergosterol on diabetic nephropathy. (2) Methods: Streptozotocin (STZ)-induced C57BL/6 diabetic mice were treated with ergosterol (10, 20, 40 mg/kg/day) for 8 weeks by oral gavage. The in vitro study employed rat mesangial cells exposed to 30 mM glucose for 48 h in the presence of 10 or 20 μM ergosterol. (3) Results: Ergosterol treatment improved body weights, ameliorated the majority of biochemical and renal functional parameters and histopathological changes, and reduced extracellular matrix (ECM) deposition in diabetic mice. In vitro, ergosterol suppressed proliferation, reduced the levels of ECM proteins, and increased the expression of matrix metalloproteinase-2 and -9 in high glucose-induced mesangial cells; Furthermore, ergosterol markedly improved transforming growth factor-β1 (TGF-β1) expression, enhanced phosphorylation levels of drosophila mothers against decapentaplegic 2 (Smad2), and regulated the downstream factors in vivo and in vitro. (4) Conclusions: Ergosterol alleviated mesangial cell proliferation and the subsequent ECM deposition by regulating the TGF-β1/Smad2 signaling pathway.


2000 ◽  
Vol 57 (3) ◽  
pp. 1027-1040 ◽  
Author(s):  
Joseph P. Grande ◽  
Henry J. Walker ◽  
Bruce J. Holub ◽  
Gina M. Warner ◽  
Dawn M. Keller ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document